DGAP-News

True Leaf Close to Completing Process for Marijuana License - Seite 2

As True Leaf goes through the ACMPR licensing process, the company has increased value for shareholders by creating its pet division, True Leaf Pet. The company has been marketing hemp-based supplements for pets since 2015, which are now distributed throughout North America and Europe. True Leaf's work in the pet industry is a valuable experience that can be leveraged to build-out the company's future health and wellness line of high-CBD cannabis products for humans when it becomes a licensed producer.

'It has been a long journey, but our mission remains the same. We intend to supply customers interested in the healing power of cannabis, to improve the quality of life of Canadians,' said True Leaf CEO Darcy Bomford.

About True Leaf:

True Leaf Medicine International Ltd., through its wholly-owned subsidiary 'True Leaf Pet', has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States and Europe. The company has also filed an application under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its 'True Leaf Medicine' subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting security clearance and 'pre-licensing inspection' approval.

www.trueleaf.com

Media Contact:
Paul Sullivan
BreakThrough Communications
[e-mail]
O: 604-685-4742
M: 604-603-7358

Investor Contact:
Kevin Bottomley
Director and Corporate Relations
[e-mail]
M: 778-389-9933

Click on, or paste the following link into your web browser, to view
the associated documents

http://www.newsfilecorp.com/release/26237

---

20.04.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---

Language:	English
Company:	True Leaf Medicine International Inc.
	Canada
ISIN:	CA89785C1077

End of News	DGAP News Service

565803  20.04.2017